日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhancement of sensitivity and quantification quality in the LC-MS/MS measurement of large biomolecules with sum of MRM (SMRM)

利用 MRM 和 (SMRM) 提高 LC-MS/MS 测量大分子生物分子的灵敏度和定量质量

Tang, Liang; Swezey, Robert R; Green, Carol E; Mirsalis, Jon C

Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo.

口服有效药物协同组合对抗埃博拉病毒的体内试验的制剂、稳定性、药代动力学和建模研究

Finch Courtney L, Dyall Julie, Xu Shuang, Nelson Elizabeth A, Postnikova Elena, Liang Janie Y, Zhou Huanying, DeWald Lisa Evans, Thomas Craig J, Wang Amy, Xu Xin, Hughes Emma, Morris Patrick J, Mirsalis Jon C, Nguyen Linh H, Arolfo Maria P, Koci Bryan, Holbrook Michael R, Hensley Lisa E, Jahrling Peter B, Schmaljohn Connie, Johansen Lisa M, Olinger Gene G, Schiffer Joshua T, White Judith M

In Vitro and In Vivo Activity of Amiodarone Against Ebola Virus

胺碘酮体外和体内抗埃博拉病毒活性

Dyall, Julie; Johnson, Joshua C; Hart, Brit J; Postnikova, Elena; Cong, Yu; Zhou, Huanying; Gerhardt, Dawn M; Michelotti, Julia; Honko, Anna N; Kern, Steven; DeWald, Lisa Evans; O'Loughlin, Kathleen G; Green, Carol E; Mirsalis, Jon C; Bennett, Richard S; Olinger, Gene G Jr; Jahrling, Peter B; Hensley, Lisa E

Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories

不同实验室大鼠心脏毒性生物标志物的评估

Kim, Kyuri; Chini, Naseem; Fairchild, David G; Engle, Steven K; Reagan, William J; Summers, Sandra D; Mirsalis, Jon C

Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy

临床前评估以确定治疗结核病的最佳利奈唑胺方案

Brown, Ashley N; Drusano, George L; Adams, Jonathan R; Rodriquez, Jaime L; Jambunathan, Kalyani; Baluya, Dodge L; Brown, David L; Kwara, Awewura; Mirsalis, Jon C; Hafner, Richard; Louie, Arnold

Tenofovir disoproxil fumarate: toxicity, toxicokinetics, and toxicogenomics analysis after 13 weeks of oral administration in mice

富马酸替诺福韦酯:小鼠口服给药13周后的毒性、毒代动力学和毒理基因组学分析

Ng, Hanna H; Stock, Howard; Rausch, Linda; Bunin, Deborah; Wang, Abraham; Brill, Shirley; Gow, Jason; Mirsalis, Jon C

Preclinical studies on the pharmacokinetics, safety, and toxicology of oxfendazole: toward first in human studies

奥芬达唑的药代动力学、安全性和毒理学临床前研究:迈向首次人体试验

Codd, Ellen E; Ng, Hanna H; McFarlane, Claire; Riccio, Edward S; Doppalapudi, Rupa; Mirsalis, Jon C; Horton, R John; Gonzalez, Armando E; Garcia, H Hugo; Gilman, Robert H

Metabolism, pharmacokinetics, tissue distribution, and stability studies of the prodrug analog of an anti-hepatitis B virus dinucleoside phosphorothioate

抗乙型肝炎病毒二核苷硫代磷酸酯前药类似物的代谢、药代动力学、组织分布和稳定性研究

Coughlin, John E; Pandey, Rajendra K; Padmanabhan, Seetharamaiyer; O'Loughlin, Kathleen G; Marquis, Judith; Green, Carol E; Mirsalis, Jon C; Iyer, Radhakrishnan P

Biodistribution, toxicology, and radiation dosimetry of 5-HT1A-receptor agonist positron emission tomography ligand [11C]CUMI-101

5-HT1A受体激动剂正电子发射断层扫描配体[11C]CUMI-101的生物分布、毒理学和辐射剂量学

Kumar, Dileep J S; Bai, Bing; Ng, Hanna H; Mirsalis, Jon C; Erlandsson, Kjell; Milak, Matthew S; Majo, Vattoly J; Prabhakaran, Jaya; Mann, J J; Parsey, R V